• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于生物制药研究的人血浆和尿液中(+)-S 氯吡格雷羧酸代谢物的毛细管区带电泳测定方法。

Capillary zone electrophoresis method for determination of (+)-S clopidogrel carboxylic acid metabolite in human plasma and urine designed for biopharmaceutic studies.

机构信息

Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 6 Swiecickiego Street, 60-781 Poznań, Poland.

出版信息

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Apr 15;878(13-14):1013-8. doi: 10.1016/j.jchromb.2010.02.033. Epub 2010 Mar 6.

DOI:10.1016/j.jchromb.2010.02.033
PMID:20346740
Abstract

Fast and reproducible Capillary Zone Electrophoresis (CZE) method for the quantification of (+)-S clopidogrel carboxylic acid metabolite in human fluids was elaborated for the first time. Optimal buffer and CZE conditions were established to obtain the complete separation of clopidogrel, its metabolite and piroxicam (internal standard), during one analytical run. Finally, resolution of the analytes was obtained in an uncoated silica capillary filled with a phosphate buffer of pH 2.5. The analytes were isolated from plasma and urine samples using solid phase extraction (SPE). Validation of the CZE method was carried out. The calibration curve of clopidogrel was linear in the range of 0.5-10.0mg/L in plasma and urine, whereas for (+)-S carboxylic acid metabolite linearity was confirmed in the range of 0.25-20.0mg/L in plasma and 0.25-10.0mg/L in urine. Intra- and inter-day precision and accuracy were repeatable. LOD and LOQ were also estimated. SPE recovery of the analytes from plasma and urine was comparable and greater than 80%. The validated method was successfully applied in pharmacokinetic investigations of (+)-S carboxylic acid metabolite of clopidogrel following the oral administration of clopidogrel to patients prior to percutaneous coronary intervention.

摘要

首次详细阐述了用于定量检测人液中(+)-S 氯吡格雷羧酸代谢物的快速且可重现的毛细管区带电泳(CZE)方法。优化了缓冲液和 CZE 条件,以便在一次分析运行中完全分离氯吡格雷、其代谢物和吡罗昔康(内标)。最后,在填充 pH 2.5 磷酸盐缓冲液的未涂层硅胶毛细管中获得了分析物的分辨率。使用固相萃取(SPE)从血浆和尿液样品中分离分析物。对 CZE 方法进行了验证。氯吡格雷在血浆和尿液中的校准曲线在 0.5-10.0mg/L 范围内呈线性,而(+)-S 羧酸代谢物在血浆中的线性范围为 0.25-20.0mg/L,在尿液中的线性范围为 0.25-10.0mg/L。日内和日间精密度和准确度均具有可重复性。还估算了 LOD 和 LOQ。从血浆和尿液中 SPE 回收分析物的效率相当且大于 80%。该验证方法成功应用于经皮冠状动脉介入术前给予氯吡格雷后氯吡格雷(+)-S 羧酸代谢物的药代动力学研究。

相似文献

1
Capillary zone electrophoresis method for determination of (+)-S clopidogrel carboxylic acid metabolite in human plasma and urine designed for biopharmaceutic studies.用于生物制药研究的人血浆和尿液中(+)-S 氯吡格雷羧酸代谢物的毛细管区带电泳测定方法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Apr 15;878(13-14):1013-8. doi: 10.1016/j.jchromb.2010.02.033. Epub 2010 Mar 6.
2
Simultaneous determination of clopidogrel and its carboxylic acid metabolite by capillary electrophoresis.采用毛细管电泳法同时测定氯吡格雷及其羧酸代谢物。
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Jun 1;878(19):1480-6. doi: 10.1016/j.jchromb.2010.03.044. Epub 2010 Mar 31.
3
Validated HPLC method for determination of carboxylic acid metabolite of clopidogrel in human plasma and its application to a pharmacokinetic study.验证的高效液相色谱法测定人血浆中氯吡格雷羧酸代谢物及其在药代动力学研究中的应用。
Biomed Chromatogr. 2006 Dec;20(12):1309-14. doi: 10.1002/bmc.697.
4
High-performance liquid chromatographic determination of inactive carboxylic acid metabolite of clopidogrel in human serum: Application to a bioequivalence study.高效液相色谱法测定人血清中氯吡格雷无活性羧酸代谢物:在生物等效性研究中的应用。
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Mar 15;864(1-2):168-72. doi: 10.1016/j.jchromb.2008.01.049. Epub 2008 Feb 8.
5
Determination of ulifloxacin, the active metabolite of prulifloxacin, in human plasma by a 96-well format solid-phase extraction and capillary zone electrophoresis.采用96孔板固相萃取和毛细管区带电泳法测定人血浆中普利沙星的活性代谢物乌利沙星。
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Sep 1;872(1-2):172-6. doi: 10.1016/j.jchromb.2008.07.033. Epub 2008 Aug 5.
6
Separation and determination of clopidogrel and its impurities by capillary electrophoresis.
J Pharm Biomed Anal. 2009 Feb 20;49(2):193-200. doi: 10.1016/j.jpba.2008.10.031. Epub 2008 Nov 5.
7
Stereoselective CZE method for analysis of verapamil and norverapamil in human plasma.
Acta Pol Pharm. 2013 May-Jun;70(3):395-401.
8
Estimation of carboxylic acid metabolite of clopidogrel in Wistar rat plasma by HPLC and its application to a pharmacokinetic study.采用高效液相色谱法测定Wistar大鼠血浆中氯吡格雷羧酸代谢物及其在药代动力学研究中的应用。
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 25;821(2):173-80. doi: 10.1016/j.jchromb.2005.05.013.
9
Enantioselective CE method for pharmacokinetic studies on ibuprofen and its chiral metabolites with reference to genetic polymorphism.
Electrophoresis. 2007 Aug;28(15):2726-37. doi: 10.1002/elps.200600736.
10
Development and validation of high-throughput liquid chromatography-tandem mass spectrometric method for simultaneous quantification of clopidogrel and its metabolite in human plasma.开发并验证了一种用于同时定量测定人血浆中氯吡格雷及其代谢物的高效液相色谱-串联质谱法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Feb 1;878(3-4):502-8. doi: 10.1016/j.jchromb.2009.12.026. Epub 2010 Jan 4.

引用本文的文献

1
Impact of selected genetic factors on clopidogrel inactive metabolite level and antiplatelet response in patients after percutaneous coronary intervention.选择的遗传因素对经皮冠状动脉介入治疗后患者氯吡格雷无活性代谢物水平和抗血小板反应的影响。
Pharmacol Rep. 2021 Apr;73(2):583-593. doi: 10.1007/s43440-020-00197-w. Epub 2020 Dec 3.
2
Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases.氯吡格雷及其代谢产物在心血管疾病患者中的临床药代动力学
Clin Pharmacokinet. 2014 Feb;53(2):155-64. doi: 10.1007/s40262-013-0105-2.